Royal Pharmaceutical Society (RPS) - News updates

Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly

Accessing wellbeing support

RPS Scotland is delighted to have been a co-signatory alongside the Chief Pharmaceutical Officer, GPhC, CPS, the Directors of Pharmacy and the National Pharmacy Technicians Group on a letter to all ph

Class 2 Medicines Recall: Intrapharm Laboratories Ltd, Mydrilate 0.5% Eye Drops 5ml

Intrapharm Laboratories Ltd are recalling a specified batch of Mydrilate 0.5 % Eye Drops 5ml as a precautionary measure due to out of specification results for related substances obtained during stabi

NHS England letter: JCVI advice in response to the emergence of the B.1.1.529 (Omicron) variant: next steps for deployment

NHS England has written to the vaccine system to set out the steps needed to support the significant acceleration of the vaccine programme. You can find a copy of this letter here. The letter include

RPS condemns abuse towards pharmacy staff

During the pandemic many pharmacy teams have reported an increase in abuse, violence and aggression from some members of the public. RPS has consistently highlighted abuse as intolerable and condemns

UPDATED PRODUCT AND BATCH - Class 2 Medicines Recall various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products

There is one additional product and batch that has been added to this recall. Further information on the affected batches and advice for healthcare professionals can be found on theMHRA website.

Increased role for community pharmacies in providing booster vaccines

Commenting on the increased role for community pharmacies in England in delivering the Covid-19 booster vaccination programme, Chair of the Royal Pharmaceutical Society in England, Ms Thorrun Govind,

Class 4 Medicines Defect Information: Diuril Oral Solution (unlicensed medicine), Mawdsley-Brooks & Company Limited

There is an error with the patient information leaflet (PIL) that has been provided with Diuril Oral Solution, supplied by Mawdsley-Brooks & Company Limited. Further information and advice for he

Class 4 Medicines Defect Information: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension

There is an error relating to the wording on the outer carton label for Mometasone Furoate 50 Microgram / Dose Nasal Spray, supplied by PilsCo Ltd. Further information and advice for healthcare profe

Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products

Specific batches of products are recalled by the Marketing Authorisation Holders and parallel distributor companies as a precautionary measure due to contamination with an impurity called 5-(4’-

Update on Omicron Variant (England)

The UK Health Security Agency’s Chief Medical Adviser, National Medical Director of NHS England, and Chief Nursing Officer for England have issued an update on COVID-19 Omicron Variant (B.1.1.52